Abstract:In this work we disclose a new family of biscyclometallated Ir( III ) complexes of the general formula [Ir(C^N) 2 (N^N)]Cl ( IrL1–IrL5 ), where HC^N is 1-phenyl-β-carboline and N^N ligands ( L1–L5 ) are different diimine ligands that differ from each other in the number of aromatic rings fused to the bipyridine scaffold. The photophysical properties of IrL1–IrL5 were thoroughly studied, and theoretical calculations were performed for a deeper comprehension of the respective variations along the series. All complexes exhibited high photostability under blue light irradiation. An increase in the number of aromatic rings led to a reduction in the HOMO–LUMO band gap causing a red-shift in the absorbance bands. Although all the complexes generated singlet oxygen ( 1 O 2 ) in aerated aqueous solutions through a photocatalytic process, IrL5 was by far the most efficient photosensitizer. Consequently, IrL5 was highly active in the photocatalytic oxidation of NADH. The formation of aggregates in DMSO at a high concentration (25 mM) was confirmed using different techniques, but was proved to be negligible in the concentration range of biological experiments. Moreover, ICP-MS studies proved that the cellular uptake of IrL2 and IrL3 is much better relative to that of IrL1 , IrL4 and IrL5 . The antiproliferative activity of IrL1–IrL5 was investigated in the dark and under blue light irradiation against different cancer cell lines. Complexes IrL1–IrL4 were found to be cytotoxic under dark conditions, while IrL5 turned out to be weakly cytotoxic. Despite the low cellular uptake of IrL5 , this derivative exhibited a high increase of cytotoxicity upon blue light irradiation resulting in photocytotoxicity indexes (PI) up to 38. IrL1–IrL4 showed lower photocytotoxicity indexes ranging from 1.3 to 17.0. Haemolytic experiments corroborated the compatibility of our complexes with red blood cells. Confocal microscopy studies proved their accumulation in mitochondria, leading to mitochondrial membrane depolarization, and ruled out their localization in lysosomes. Overall, the mitochondria-targeted activity of IrL5 , which inhibits considerably the viability of cancer cells upon blue light irradiation, allows us to outline this PS as a new alternative to traditional chemotherapeutic agents.

Photoacidolysis-Mediated Iridium(III) Complex for Photoactive Antibacterial Therapy

Cuprous Oxide–demethyleneberberine Nanospheres for Single Near-Infrared Light-Triggered Photoresponsive-Enhanced Enzymatic Synergistic Antibacterial Therapy

Dipyrrinato‐Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation

An AIE Metal Iridium Complex: Photophysical Properties and Singlet Oxygen Generation Capacity

2‐thiophenyl‐isoquinoline Ir(III) complex as red absorbing photosensitizer: a promising tool in antipseudomonal photodynamic therapy

Precise ligand engineering of Ir(III)-based photosensitizer with aggregation-induced emission for image-guided photodynamic therapy

An AIE-Active Cyclometalated Iridium(III) Photosensitizer for Selective Discrimination, Imaging, and Synergistic Elimination of Gram-Positive Bacteria

Computational Study of the Photophysical Properties and Electronic Structure of Iridium(III) Photosensitizers Complexes with Electron-withdrawing Groups

Towards efficient Ir(iii) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands

Disulfide-Bridged Cationic Dinuclear Ir(III) Complex with Aggregation-Induced Emission and Glutathione-Consumption Properties for Elevating Photodynamic Therapy

An Iridium (III) Complex Bearing a Donor–Acceptor–Donor Type Ligand for NIR‐Triggered Dual Phototherapy

Cellular membrane-targeting ruthenium complexes as an efficient photosensitizer for broad-spectrum antibacterial activity

Hypoxia-Active Iridium(III) Bis-terpyridine Complexes Bearing Oligothienyl Substituents: Synthesis, Photophysics, and Phototoxicity toward Cancer Cells

AIPE-Active Ir(III) Complexes with Tuneable Photophysical Properties and Application in Mitochondria-Targeted Dual-Mode Photodynamic Therapy.

Multiphoton Absorption Iridium(III)-Organotin(IV) Dimetal Complex with AIE Behavior for Both Sensitive Detection of Tyrosine and Antibacterial Activity

Near-infrared photochromic diarylethene iridium (III) complex.

AIE-based ruthenium complexes as photosensitizers for specifically photo-inactivate gram-positive bacteria

Lysosome-targeted Cyclometalated Ir(III) Complexes as Photosensitizer/Photoredox Catalysis for Cancer Therapy

Cellular Membrane-Targeting Ruthenium Complexes As Efficient Photosensitizers for Broad-Spectrum Antibacterial Activity.

A Photodynamic and Photochemotherapeutic Platinum‐Iridium Charge‐Transfer Conjugate for Anticancer Therapy

Construction of Robust Iridium(III) Complex-Based Photosensitizer for Boosting Hydrogen Evolution